Literature DB >> 20702499

Association of IL-6, hypothalamus-pituitary-adrenal axis function, and depression in patients with cancer.

Christian Friedrich Jehn1, Dagmar Kühnhardt, Andrea Bartholomae, Sebastian Pfeiffer, Peter Schmid, Kurt Possinger, Bernd Christian Flath, Diana Lüftner.   

Abstract

BACKGROUND: Evidence suggests that cytokines (IL-6) and alteration of the hypothalamic-pituitary-adrenal (HPA) axis play a crucial role in the etiology of depression. Patients with cancer show elevated prevalence rates for depression. The objective of this cross-sectional study was to investigate the associations between these abnormalities and depression.
METHODS: Plasma concentrations of IL-6 and cortisol were measured in cancer patients with (N = 31) and without depression (N = 83). The relative diurnal variation of cortisol (cortisol VAR), expressed in percentage, was calculated.
RESULTS: There was a significant difference in median plasma concentration of IL-6 between the patients with depression and those without (18.7 vs 2.7 pg/mL; P < .001). Relative cortisol VAR was decreased in depressed patients as compared with patients without depression (11.72% vs 60.6%, P = .037). A positive correlation between the depressive symptoms and IL-6 concentration was found (r = 0.469, P < .001). Negative correlations were found between cortisol VAR versus depressive symptoms and cortisol VAR versus IL-6 (r = -0.6, P < .001 and r = -0.52, P < .001, respectively). IL-6 (odds ratio [OR] = 1.1; 95% confidence interval [CI] = 1.0-1.2; P = .006) and cortisol VAR (OR = 1.3; 95%CI = 1.0-1.4; P = .02) are independently associated with depression.
CONCLUSIONS: Depression in cancer is associated with increased plasma IL-6 concentrations and dysfunction of the HPA axis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20702499     DOI: 10.1177/1534735410370036

Source DB:  PubMed          Journal:  Integr Cancer Ther        ISSN: 1534-7354            Impact factor:   3.279


  21 in total

Review 1.  The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications--a review.

Authors:  Antonio Macciò; Clelia Madeddu
Journal:  J Mol Med (Berl)       Date:  2013-09-21       Impact factor: 4.599

2.  SNPs in PTGS2 and LTA predict pain and quality of life in long term lung cancer survivors.

Authors:  Sarah M Rausch; Brian D Gonzalez; Matthew M Clark; Christi Patten; Sara Felten; Heshan Liu; Yafei Li; Jeff Sloan; Ping Yang
Journal:  Lung Cancer       Date:  2012-03-29       Impact factor: 5.705

Review 3.  Biomarkers: symptoms, survivorship, and quality of life.

Authors:  Christine Miaskowski; Bradley E Aouizerat
Journal:  Semin Oncol Nurs       Date:  2012-05       Impact factor: 2.315

4.  Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer Study.

Authors:  Jeanne S Mandelblatt; Tim A Ahles; James C Root; Xingtao Zhou; Jaeil Ahn; Brent J Small; Wanting Zhai; Traci Bethea; Judith E Carroll; Harvey Jay Cohen; Asma Dilawari; Martine Extermann; Deena Graham; Claudine Isaacs; Paul B Jacobsen; Heather Jim; Brenna C McDonald; Zev M Nakamura; Sunita K Patel; Kelly Rentscher; Andrew J Saykin; Kathleen Van Dyk
Journal:  Breast Cancer Res Treat       Date:  2022-05-19       Impact factor: 4.624

5.  Depression, Antidepressant Use, and Postmenopausal Breast Cancer Risk.

Authors:  Susan B Brown; Susan E Hankinson; Kathleen F Arcaro; Jing Qian; Katherine W Reeves
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-11-17       Impact factor: 4.254

6.  Associations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patients.

Authors:  Masatoshi Inagaki; Tatsuo Akechi; Toru Okuyama; Yuriko Sugawara; Hiroya Kinoshita; Yasuo Shima; Kimio Terao; Shuichi Mitsunaga; Atsushi Ochiai; Yosuke Uchitomi
Journal:  Support Care Cancer       Date:  2013-02-28       Impact factor: 3.603

Review 7.  Inflammation: a mechanism of depression?

Authors:  Qiu-Qin Han; Jin Yu
Journal:  Neurosci Bull       Date:  2014-05-16       Impact factor: 5.203

8.  Neuroimmune endocrine effects of antidepressants.

Authors:  Marco Antonioli; Joanna Rybka; Livia A Carvalho
Journal:  Neuropsychiatr Dis Treat       Date:  2012-02-07       Impact factor: 2.570

9.  The Metabolomic Underpinnings of Symptom Burden in Patients With Multiple Chronic Conditions.

Authors:  Elizabeth J Corwin; Glenna Brewster; Sandra B Dunbar; Jessica Wells; Vicki Hertzberg; Marcia Holstad; Mi-Kyung Song; Dean Jones
Journal:  Biol Res Nurs       Date:  2020-09-11       Impact factor: 2.522

10.  Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability.

Authors:  Andrew Schrepf; Lauren Clevenger; Desire Christensen; Koen DeGeest; David Bender; Amina Ahmed; Michael J Goodheart; Laila Dahmoush; Frank Penedo; Joseph A Lucci; Parvin Ganjei-Azar; Luis Mendez; Kristian Markon; David M Lubaroff; Premal H Thaker; George M Slavich; Anil K Sood; Susan K Lutgendorf
Journal:  Brain Behav Immun       Date:  2012-08-05       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.